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Information in practice
Use of cumulative mortality data in patients with acute
myocardial infarction for early detection of variation in
clinical practice: observational study
Richard A Lawrance, Micha F Dorsch, Robert J Sapsford, Alan F Mackintosh, Darren C Greenwood,
Beryl M Jackson, Christine Morrell, Michael B Robinson, Alistair S Hall for the EMMACE
(Evaluation of Methods and Management of Acute Coronary Events) Study Group
Abstract
Objectives Use of cumulative mortality adjusted for
case mix in patients with acute myocardial infarction
for early detection of variation in clinical practice.
Design Observational study.
Setting 20 hospitals across the former Yorkshire
region.
Participants All 2153 consecutive patients with
confirmed acute myocardial infarction identified
during three months.
Main outcome measures Variable life›adjusted
displays showing cumulative differences between
observed and expected mortality of patients; expected
mortality calculated from risk model based on
admission characteristics of age, heart rate, and
systolic blood pressure.
Results The performance of two individual hospitals
over three months was examined as an example. One,
the smallest district hospital in the region, had a series
of 30 consecutive patients but had five more deaths
than predicted. The variable life›adjusted display
showed minimal variation from that predicted for the
first 15 patients followed by a run of unexpectedly
high mortality. The second example was the main
tertiary referral centre for the region, which admitted
188 consecutive patients. The display showed a period
of apparently poor performance followed by
substantial improvement, where the plot rose steadily
from a cumulative net lives saved of − 4 to 7. These
variations in patient outcome are unlikely to have
been revealed during conventional audit practice.
Conclusions Variable life›adjusted display has been
integrated into surgical care as a graphical display of
risk›adjusted survival for individual surgeons or centres.
In combination with a simple risk model, it may have a
role in monitoring performance and outcome in
patients with acute myocardial infarction.
Introduction
The UK Department of Health has recently published
a national service framework for coronary artery
disease, which aims to coordinate efforts to improve
medical care of patients by the implementation of
minimal standards of care and audit.1 Many risk mod›
els have been derived in an attempt to reliably compare
care at different centres. It is self evident that if a doctor
or hospital is responsible for a high proportion of sick
patients then simply assessing crude mortality will
result in an unfavourable comparison of care. Most of
the risk›adjusted models that have been derived suffer
from overcomplexity, exclude substantial proportions
of patients with higher risk profiles, use administrative
data without clinical details, or are applicable only to
selected subgroups.2 3 We have developed a model
based on three objective admission clinical
characteristics—age, heart rate, and systolic blood pres›
sure. We have validated our model with subgroups of
our patients with acute myocardial infarction, and it
seems to accurately reflect patient outcome.4–6
Scoring systems, such as the Parsonnet score,7 have
been used to assess individual surgeons’ performance
by comparing actual and expected death rates.
Lovegrove et al have described the variable life›
adjusted display,8 a graphical technique based on the
cumulative sum (cusum) method9 10 that incorporates
information of estimated risks for each individual case.
Cusum charts record successive cases horizontally, with
plots ascending by single units for each outcome event
(such as death) reached. The variable life›adjusted dis›
play incorporates outcome information, simultane›
ously accounting for prior estimated risk in each case
and plotting the difference in cumulative expected and
observed mortality. Sherlaw›Johnson et al recently
described a method for estimating variability for such
displays in order to assess the probability that observed
deviations occurred as a result of chance rather than
because of a difference in quality of care.11
In this study we extend the use of variable
life›adjusted displays in combination with a simple,
accurate, and validated risk model for assessing care of
patients with acute myocardial infarction and suggest
indications for more detailed review of patient care.
Subjects and methods
Patient population
Between 1 September and 30 November 1995, 3684
potential recruits to the evaluation of methods and
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management of acute coronary events (EMMACE)
study were identified in the 20 adjacent hospitals that
comprised all units in the former Yorkshire region that
admitted patients with acute myocardial infarction. We
identified potential recruits from coronary care
registers, clinical coding, and biochemistry records of
requests for cardiac enzyme assays. We evaluated the
patients’ medical records and confirmed 2153 con›
secutive cases of acute myocardial infarction according
to either the World Health Organization’s criteria or to
the clinical diagnosis reached by the attending
physician. We included these 2153 patients, of whom
1643 were discharged from hospital alive after a first
myocardial event, in our study. For data abstraction, we
applied a hierarchical system of preferred data sources
to maintain consistency among our research assistants:
for example, we used the first recorded blood pressure
and heart rate obtained from either the accident and
emergency department or from medical or nursing
notes.
We completed a 250 item record of demographic,
clinical, and treatment variables for each patient
according to a standardised operations manual and
entered the data on a computer database. We included
all consecutive patients with acute myocardial infarc›
tion regardless of age or place of care within a hospital.
We considered only patients’ first presentation with
acute myocardial infarction (during the recruitment
window), and patients transferred to a tertiary centre
were counted only once for their index admission. We
recorded patients’ clinical characteristics on admission
from the following sources in order of preference: (a)
emergency department medical notes, (b) the admit›
ting medical team’s first clerking, or (c) nursing notes.
Calculation of expected mortality
We developed and externally validated a risk model
with a demonstrable clinical utility in stratifying
patients after myocardial infarction.4 5 The model
calculates an individual’s probability of death at 30 days
(P30) on the basis of three robust admission characteris›
tics (age, heart rate, and systolic blood pressure). The
calculation is
P30 = 1/(1 + exp( − L30)),
where
L30 = − 5.624 + (0.085×age) + (0.014×heart rate) −
(0.022×systolic blood pressure).
In our patient cohort its accuracy was demon›
strated by the area under the receiver›operating
characteristics (ROC) curve of 0.78. For the patients
studied, the mean expected 30 day mortality was 23.5%
and the observed mortality was 24.4%, giving a stand›
ardised mortality ratio of 1.04.
Variable life›adjusted display
Using the variable life›adjusted display, we can
illustrate the cumulative mortality for a hospital or an
individual doctor and the variation either side of that
predicted. By calculating a patient’s expected probabil›
ity of death after myocardial infarction, we can also
estimate the probability of survival. The line plotted in
this graphical display varies about zero, ascending, for
a patient who survives, by an amount equivalent to the
estimated probability of death. For those patients who
die by 30 days, the plot descends by an amount equal
to the estimated probability of survival. It can be shown
that there is a proportionally greater shift in the plot
for patients with unexpected outcomes.
We examined two hospitals for variations in
risk›adjusted 30 day survival over the three month
period of study—hospital A, the smallest of the district
hospitals studied, and hospital B, the supraregional
tertiary referral centre for the area.
Results
The variable life›adjusted displays (figs 1 and 2) show
the number of cases on the x axis and the cumulative
difference between the predicted and observed deaths
on the y axis. Figure 1 shows the results for hospital A,
the centre with the highest standardised mortality ratio.
This small hospital had a series of only 30 patients with
acute myocardial infarction. The observed and
expected mortalities were 44.2% and 27.5% respec›
tively (standardised mortality ratio 1.61). The risk
model would predict eight deaths, whereas the actual
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Fig 1 Variable life›adjusted display of a small cottage hospital for a
series of 30 consecutive patients with acute myocardial infarction.
Predicted mortality was calculated by a validated risk score based on
admission characteristics of age, systolic blood pressure, and heart
rate
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Fig 2 Variable life›adjusted display of a large teaching hospital and
regional cardiac centre for a series of 188 consecutive patients with
acute myocardial infarction. Predicted mortality was calculated by a
simple risk score based on admission characteristics of age, systolic
blood pressure, and heart rate
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number was 13. The display reveals minimal variation
from that predicted for the first 15 patients followed by
a run of unexpectedly high mortality.
Figure 2 shows the for hospital B, which admitted
188 patients with acute myocardial infarction during
the study period. The plot terminates with 3.5 extra
“lives” above expected (observed number of deaths 42,
expected 45.5; standardised mortality ratio 0.92).
Between case numbers 35 and 135 the plot ascends
from a cumulative (expected minus observed) net lives
gained of − 4 to 7.
Discussion
Using just patients’ age, blood pressure, and heart rate
to adjust for case mix, we derived a continuous plot to
compare observed and expected outcome for patients
with acute myocardial infarction.
The main purpose of audit is to provide high quality
data analyses with which to monitor the required stand›
ards and to allow clinicians to evaluate the performance
of their units. Block audit, however, is retrospective and
does not allow immediate identification, and thus rectifi›
cation, of potential problems. With application of a
simple risk›adjusted model to populations of patients
with acute myocardial infarction, we have produced
variable life›adjusted displays. Such plots have become
increasingly integrated into surgical care, allowing
immediate monitoring of performance for individual
surgeons or units over time, but they are not yet used in
routine audit of medical patients.
Recently, Sherlaw›Johnson et al showed that
prediction intervals can be derived for plots of
standardised mortality ratio, with the preoperative case
mix taken into account.11 We did not calculate
prediction intervals for our populations because we
consider that the usefulness of the graphical displays is
enhanced by being qualitative rather than quantitative.
We do not consider that achievement of a P value less
than 0.05 is helpful in the context of continuous, real
time monitoring, nor should it provide evidence that is
not in keeping with other qualitative indicators. For
example, if hospital B (fig 2) had a major shortage of
beds in its coronary care unit beds that coincided with
the period of increased deaths, actions might be taken
even without a significant P value. Although an appar›
ent run of poor results may not represent a real
change, a failure to act on the qualitative trend
observed until a significant P value had been achieved
could result in the needless loss of life.
Our display method of monitoring performance or
outcome over time can be used as an early warning
system to allow more detailed audit to be performed.12
For example, the sharp descent of the plot in the
second half of figure 1 highlights the possibility of poor
performance. Conversely, in figure 2 the graph ascends
from a cumulative net lives saved of − 4 to 7 in the
space of 100 consecutive cases, suggesting that any
possible problem in the hospital was identified and
corrected. Such periods of poor or above average per›
formance are liable to be missed with block audit,
especially when the overall figures are not significantly
different from those forecast. As stated by de Mol when
commenting on the original description of the variable
life›adjusted display,13 differences in care measured by
patient outcome are common. A judgment of whether
this performance is above or below average could be
based on predefined limits in order to adequately iden›
tify important outliers as well as permitting more cost
effective and logical use of audit time. However, we
would further suggest that rigorous application of a P
value (which is itself subject to errors in the context of
multiple observations) may mean that early qualitative
trends towards harm remain unheeded. Solely relying
on quantification of variability in performance rather
than a qualitative assessment is therefore laden with
shortcomings.14 A hypothetical example of this
limitation is that 16 of 160 patients would have to die
after routine cardiac surgery (10% mortality) before a
statistically significant doubling of deaths could be
detected with 90% chance.15 16 Common sense suggests
that such a trend should be identified and corrected
long before the problem was so far progressed,
especially if other strong qualitative indicators were
present.
Any risk model can become less accurate over time
because of progressive improvements in care. The Par›
sonnet scoring system, derived in 1989, has consist›
ently been shown to predict risk strata that correlate
with the observed mortality in adult acquired heart
disease. However, it equally consistently overestimates
the risk of contemporary coronary surgery by up to
100%.7 17 18 In order to avoid this problem if our model
were to be in general use, we would recommend that
patients’ heart rate and blood pressure on admission
should be added to the core dataset of the national
service framework for coronary artery disease. If
hospitals were then to provide the data required for the
risk model to a centralised database the model could
be continually updated and made available on the
internet. This would reduce the likelihood of
overestimating risk in patients with acute myocardial
infarction.
What is already known on this topic
The national service framework for coronary
artery disease requires minimal standards of care
and audit of patients with acute myocardial
infarction but does not integrate clinical status into
the audit tool
Predictive models using only a few factors to
adjust for case mix are easy to use and may be as
accurate as more complicated methods
Early identification of variations in patient
outcome is not revealed by block audit, and,
instead, a continuous monitoring process is
required
What this study adds
Using just patients’ age, blood pressure, and heart
rate to adjust for case mix, a continuous plot can
be derived to compare observed and expected
outcome for patients with acute myocardial
infarction
This method of monitoring outcome over time
can be used as an early warning system to allow
more detailed audit to be performed
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As stated in the national service framework
documentation, good quality data can provide a
powerful engine for change and improvement. The
method we describe constitutes an improvement over
simple clinical intuition and has a potentially
important role in indicating the need for more detailed
audit. In the interests of patient safety, we suggest that
there is a need for continuous, qualitative observations
of deviations from expected outcomes.
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Life hangs on chance and the generosity of others
Laura came to us from the paediatric cystic fibrosis centre when
she was 16 years old. She had severe lung disease and been
placed on the transplant list in January 1997. She had just
completed her GCSEs and had got top marks. She had just
started her A levels and wanted to study theatre and drama at
university. Her disease progressed; we put her on to overnight
ventilation and permanent intravenous antibiotics.
Our patients listed for transplantation continued to die on the
waiting list because of the shortage of donors. Laura’s activities
became more limited at school, and she needed help with
mobility and portable oxygen. Characteristically, despite her
limitations and against advice, she went on theatre trips to
London and Dublin. Last summer, she completed her A levels
and came into hospital exhausted from her efforts. She picked up
a cold in hospital and deteriorated. Her chest radiograph showed
confluent shadowing associated with terminal disease.
Claire, a close friend with severe disease, came back from
holiday with a severe chest infection. Laura and Claire were too
breathless to visit each other, although they were only a few
rooms apart. Claire failed to respond and became breathless
despite high flow oxygen. She asked us to allow her to die
comfortably. We withdrew the antibiotics, and she died
comfortably surrounded by her family.
Laura had now been in hospital for seven weeks and was
bedbound. I told her mother that she would probably die. We
informed the transplant team that the situation was desperate.
Laura had now been on the transplant list for three years. At the
ward round, we decided that medical treatment had failed and
agreed to discuss with Laura as to whether she would like us to
stop treatment as she was suffering so much. I went to see her on
my own at the end of the ward round to talk to her about dying,
but, just as I started, the sister came in to tell me the senior
transplant surgeon was on the phone; I had talked to him that
morning about potential donors and he wondered whether Laura
was now too sick to transplant. Now he told me that they had
found a suitable donor.
I went back to Laura and now spoke to her about living rather
than the dying as I had intended a few moments before. That
night Laura received her transplant. After a stormy postoperative
period, she was extubated on the day the A level results came out;
her university place was assured with two As and a B. Nearly a
year later she continues to prosper, talking continuously, taking a
gap year before university, and sending emails under the name of
demolition babe (I thought at first it was a virus).
We don’t have enough organ donors. Other countries do better
than us. The current government needs to do more, but currently
two out of three transplant units (Sheffield, Birmingham, and
Manchester) are proposed to close. Although all three sites were
inspected over a year ago, the government has still not released
the decision.
How can organ donation be improved? It might help if it was
known that the current minister of health was on the donor
registry. Is the prime minister? How many members of the
cabinet are on the donor registry? The number of people
carrying donor cards might increase if there was top down
government support.
Anthony Kevin Webb clinical director,Manchester Adult Cystic
Fibrosis Unit,Wythenshawe Hospital, South Manchester Trust
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